Evidence map›Paper›PMID 32486107›Full record

ReviewMicroorganisms2020

Bioactive Secondary Metabolites from

Raja Asad Ali Khan, Saba Najeeb, Shaukat Hussain, Bingyan Xie, Yan Li

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
34.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 294 citations in OpenAlex.

  1. Global trends inFrontiers in microbiology · 2025
    Pooled it
  2. Journal of fungi (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Rapid Discovery of Antifungal α-Pyrone Analogs fromJournal of fungi (Basel, Switzerland) · 2026
    Article
  10. In-vitro evaluation of selected nativeFrontiers in microbiology · 2026
    Article
  11. Review
  12. Review
  13. Mechanisms of action and biocontrol potential ofFrontiers in fungal biology · 2026
    Review
  14. Article
  15. Journal of fungi (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Biocontrol Potential of NativeJournal of fungi (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Raja Asad Ali KhanInstitute of Vegetables and Flowers (Plant Pathology Lab), Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Saba NajeebInstitute of Vegetables and Flowers (Plant Pathology Lab), Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Shaukat HussainDepartment of Plant Pathology, The University of Agriculture, Peshawar 25130, Pakistan.
Bingyan XieInstitute of Vegetables and Flowers (Plant Pathology Lab), Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Yan LiInstitute of Vegetables and Flowers (Plant Pathology Lab), Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Institute of Vegetables and Flowers · CNThe University of Agriculture, Peshawar · PK

Funding

Central Public-interest Scientific Institution Basal Research Fund IVF-BRF2019012National Key R&D Program of China 2018YFD0201200
6 · The paper itself

Abstract

Phytopathogenic fungi, causing significant economic and production losses, are becoming a serious threat to global food security. Due to an increase in fungal resistance and the hazardous effects of chemical fungicides to human and environmental health, scientists are now engaged to explore alternate non-chemical and ecofriendly management strategies. The use of biocontrol agents and their secondary metabolites (SMs) is one of the potential approaches used today.

Indexed as

antifungalbiological controlphytopathogenic fungisecondary metabolitesTrichoderma

Identifiers

PMID32486107
PMCPMC7356054
OpenAlexW3031002027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.